化合物简介
SCH-530348 is a novel antiplatelet agent undergoing development by Schering-Plough Corp for the treatment and prevention of atherothrombosis. It is currently undergoing Phase-III clinical trials for acute coronary syndrome (unstable angina/non-ST segment elevation myocardial infarction) and secondary prevention of cardiovascular events in high-risk patients.
基本信息
中文名称
沃拉帕沙硫酸盐
英文名称
Vorapaxar sulfate
中文别名
硫酸沃拉帕沙
英文别名
ethyl N-[(1R,3aR,4aR,6R,8aR,9S,9aS)-9-[(E)-2-[5-(3-fluorophenyl)pyridin-2-yl]ethenyl]-1-methyl-3-oxo-3a,4,4a,5,6,7,8,8a,9,9a-decahydro-1H-benzo[f][2]benzofuran-6-yl]carbamate,sulfuric acid、ethyl ((1R,3aR,4aR,6R,8aR,9S,9aS)-9-((E)-2-(5-(3-fluorophenyl)pyridin-2-yl)vinyl)-1-methyl-3-oxododecahydronaphtho[2,3-c]furan-6-yl)carbamate sulfate、Sch 530348
CAS号
705260-08-8
分子式
C29H35FN2O8S
分子量
590.66
精确质量
590.21
PSA
160.5
LOGP
6.4484
编号系统
UNII
IN66038E6C
